GLP-1 receptor agonists (semaglutide, tirzepatide, liraglutide) work by suppressing appetite, slowing digestion, and regulating blood sugar leading to significant, often rapid weight loss
In a mouse model of the GLP-1R agonist semaglutide, researchers found that semaglutide administration led to a significant decrease in body weight in treated mice while attenuating the expected decrease in energy expenditure due to the decrease in weight [47]
Cook a batch of brown rice or quinoa
They showed better effects in improving mouse motor function scores, promoting the repair and regeneration of synapses or dopaminergic neurons (TH+, GDNF, synaptophysin), and inhibiting neuroinflammatory responses (IBA-1, IL-2) compared to liraglutide and DA-JC1, highlighting the advantage of targeting more sites